Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

British Journal of Pharmacology

Volumn 126, Issue 4, 1999, Pages 911-924

  Colado, M I ^a   O'Shea, E ^a   Granados, R ^b   Esteban, B ^a   Martin, A B ^b   Green, A R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

3,4 Methylenedioxymethamphetamine; 5 Hydroxytryptamine; Clomethiazole; Dopamine; Ecstasy; Free radicals; Haloperidol; L DOPA; Neurodegeneration

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; BENSERAZIDE; CLOMETHIAZOLE; DOPAMINE; FREE RADICAL; GENTISIC ACID; HALOPERIDOL; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SEROTONINERGIC NERVE CELL;

EID: 0032962796     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702373     Document Type: Article

References (68)

1. BALDWIN, H.A., COLADO, M.I., MURRAY, T.K., DE SOUZA, R.J. & GREEN, A.R. (1993). Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br. J. Pharmacol., 108, 590-596.
2. BALDWIN, H.A., WILLIAMS, J.L., SNARES, M., FERREIRA, T., CROSS, A.J. & GREEN, A.R. (1994). Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br. J. Pharmacol., 112, 188-194.
3. BATTAGLIA, G., YEH, S.Y., O'HEARN, E., MOLLIVER, M.E., KUHAR, K.J. & DE SOUZA, E.B. (1987). 3,4-methyIenedioxyamphetamine destroys serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]-paroxetine-labelled serotonin uptake sites. J. Pharmacol. Exp. Ther., 242, 911-916.
4. BROENING, H.W., BOWYER, J.F. & SLIKKER JR, W. (1995). Age dependent sensitivity of rats to the long term effects of the serotonergic neurotoxicant (-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMAinduced thermal response. J. Pharmacol. Exp. Ther., 275, 325333.
5. CALLA WAY, C.W. & GEYER, M.A. (1992). Stimulant effects of 3,4methylenedioxymethamphetamine in the nucleus accumbens of rats. EUT. J. Pharmacol, 214, 45-51.
6. CALLAWAY, C.W., WING, L.L. & GEYER, M.A. (1990). Serotonin release contributes to the locomotor stimulant effects of 3,4methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther., 254, 456-464.
7. CHIUEH, C.C., KRISHNA, G., TULSI, P., OBATA, T., LANG, K., HUANG, S.J. & MURPHY, D.L. (1992). Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effect of MPP. Free Rad. Biol. Med., 13, 581-583.
8. CHIUEH, C.C., MIYAKE, H. & PENG, M.-T. (1993). Role of dopamine autoxidation, hydroxyl radical generation and calcium overload in underlying mechanisms involved in MPTP-induced Parkinsonism. Adv. Neural., 60, 251-258.
9. COLADO, M.I., ESTEBAN, B., O'SHEA, E., GRANADOS, R. & GREEN, A.R. (1998a). Studies on the protective effect of pentobarbitone on MDMA-induced neurodegeneration. Psycliopharmacology, (In press).
10. COLADO, M.I., GRANADOS, R., O'SHEA, E., ESTEBAN, B. & GREEN, A.R. (1998b). Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced degeneration, comparison with the novel NMDA channel blocker AR-R15896. Br. J. Pharmacol., 124, 479-484.
11. COLADO, M.I., O'SHEA, E., ESTEBAN, B., GRANADOS, R. & GREEN, A.R. (1998c). In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism. Neuropharmacology, (In press).
12. COLADO, M.I. & GREEN, A.R. (1994). A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Br. J. Pharmacol., Ill, 131-136.
13. COLADO. M.I., MURRAY, T.K. & GREEN, A.R. (1993). 5-HT loss in rat brain following 3,4-methyIenedioxymethamphetamine (MDMA), /)-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br. J. Pharmacol.. 108, 583-589.
14. COLADO, M.I., O'SHEA, E., GRANADOS, R., MISRA, A., MURRAY, T.K. & GREEN, A.R. (I997a). A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br. J. Pharmacol., 121, 827-833.
15. COLADO, M.I., O'SHEA, E., GRANADOS, R., MURRAY, T.K., WILLIAMS, J.L. & GREEN, A.R. (1997b). In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("Ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol.. 121, 889-900.
16. COLADO, M.I., WILLIAMS, J.L. & GREEN, A.R. (1995). The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metaboliser phenotype. Br. J. Pharmacol.. 115, 1281-1289.
17. CRESPI, D., MENNINI, T. & GOBBI, M. (1997). Carrier dependent and Ca2+ dependent 5-HT and dopamine release induced by ( + )amphetamine, 3,4-methylenedioxyamphetamine, p-chloroamphetamine and fenfluramine. Br. J. Pharmacol., 121, 1735-1743.
18. FARFEL, CM. & SEIDEN, L.S. (1995a). Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments with 3,4-methylenedioxymethamphetamine, dizocilpine, COS 19755 and NBQX. J. Pharmacol. Exp. Ther., 272, 860-867.
19. FARFEL, C.M. & SEIDEN, L.S. (1995b). Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther., 272, 868-875.
20. FISCHER, J.F. & CHO, A.K. (1979). Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther., 208, 203-209.
21. GIBB, J.W., JOHNSON, M., STONE, D. & HANSON, G.R. (1990). MDMA: historical perspectives. Ann. N. Y. Acad. Sei., 600,601 611.
22. GIFFORD, A.N., MINABE, Y., TOOR, A., WANG, R.Y. & ASHBY JR. C.R. (1996). Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons. Synapse, 23, 52-57.
23. GIOVANNI, A., LIANG, L.P., HASTINGS, T.G. & ZIGMOND, M.J. (1995). Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem.. 64, 1819-1825.
24. GOUGH, B., ALI, S.F., SLIKKER JR, W. & HOLSON, R.R. (1991). Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monomines in rat caudate. Pharmacol. Biochem. Behav., 39, 619-623.
25. GREEN, A.R. (1998). Clomethiazole (Zendra") in acute ischémie stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol. Tlier.. 80, 123- 147.
26. GREEN, A.R., CROSS, A.J. & GOODWIN, G.M. (1995). Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'). Psychopharmacology. 119,247-260.
27. GREEN, A.R.. DE SOUZA, R.J., WILLIAMS, J.L., MURRAY, T.K. & CROSS, A.J. (1992). The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropliarmacology, 31, 315-321.
28. GUDELSKY, G.A., YAMAMOTO, B.K. & NASH, J.F. (1994). Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. Eur. J. Pharmacol.. 26-4, 325-330.
29. HALLIWELL, B., KAUR, H. & INGELMAN-SUNDBERG. M. (1991). Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Rad. Biol. Med., 10, 439-441.
30. HEWITT, K.E. & GREEN, A.R. (1994). Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy'). Neuropharmacology, 33, 1589- 1595.
31. HIRAMATSU, M. & CHO, A.K. (1990). Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology, 29, 269-275.
32. HIRAMATSU, M., KUMAGAI, Y., UNGER, S.E. & CHO, A.K. (1990). Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther., 254, 521-527.
33. JOHNSON, M., ELAYAN, I., HANSOM, G.R., FOLTZ, R.L., GIBB, J.W. & LIM, U.K. (1992). Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther., 261, 447-453.
34. JOHNSON, M.P., HUFFMAN, A.J. & NICHOLS, D.E. (1986). Effects of the enantiomers of MDA, MDMA and related analogues on [3H]-serotonin and [3H]-dopamine release from superfused rat brain slices. Eur. J. Pharmacol.. 132, 269-276.
35. JOHNSON, M.P., HUANG, X. & NICHOLS, D.E. (1991). Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a non-neurotoxic 3,4-methyIenedioxymethamphetamine (MDMA) analogue. Pharmacol. Biochem. Behav., 40, 915-922.
36. KATO, T., DONC, B., ISHII, K. & KINEMUCHI, H. (1986). Brain dialysis: In vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats. J. Neurochem., 46, 1277-1282.
37. KELLY, P.H., SEVIOUR, P.H. & IVERSEN, S.D. (1975). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res., 94,507-522.
38. KIL, H.Y., ZAHNG, J. & PIANTADOSI, L.A. (1996). Brain temperature alters hydroxyl radical production during cerebral ischemia/ reperfusion in rats. J. Cereb. Blood Flow Afelab., 16, 100-106.
39. KÖNIG, J.F.R. & KLIPPEL, R.A. (1963). The rat brain. A Stereotaxic atlas of the forebrain and lower parts of the brain stem. New York, Robert E Krieger Publishing Co. Inc.
40. LAVERTY, R. & LOGAN, B.J. (1990). Protection by MK801 and other drugs of methylenedioxymethamphetamine (MDMA) neurotoxicity in rats and mice. Eur. J. Pharmacol., 183, 451-452.
41. LEONARDI, E.T.K. & AZMITIA, E.G. (1994). MDMA (Ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology, 10,231-238.
42. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Client., 193, 265-275.
43. MALBERG, J.E., SABOL, K.E. & SEIDEN, L.S. (1996). Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J. Pharmacol. Exp. Ther., 278, 258-267.
44. McMILLEN, B.A. (1983). CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol. Sei., 4, 429-432.
45. MOLLIVER, M.E., BERGER, U.V., MANOUNAS, L.A., MOLLIVER, D.L., O'HEARN, E. & WILSON, M.A. (1990). Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N.Y. Acad. Sei., 600, 640-661.
46. MURRAY, T.K., WILLIAMS, J.L., MISRA, A., COLADO, M.I. & GREEN, A.R. (1996). The spin trap reagent PEN attennuates degeneration of 5-HT neurons in rat brain induced by pchloroamphetamine but not fenfluramine. ffeuropharmacology, 35, 1615-1620.
47. NASH, J.F. (1990)'. Ketanserin pretreatment attenuates MDMAinduced dopamine release in the striatum as measured by in vivo microdialysis. Life Sei., 47, 2401 -2408.
48. NASH, J.F. & BRODKIN, J. (1991). Microdialysis studies on 3,4methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J. Pharmacol. Exp. Ther., 259,820-825.
49. O'HEARN, E., BATTAGLIA, G., DE SOUZA, E.B., KUHAR, M.J. & MOLLIVER, M.E. (1988). Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause ablation of serotonergic nerve terminals in forebrain: immunocytochemical evidence. J. Neurosci., 8, 2788-2803.
50. RAITERI, M., CERRITO, F., CERVONI, A.M. & LEV], G. (1979). Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther., 208, 195-202.
51. SCHMIDT, C.J. (1987). Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther., 240, 1-7.
52. SCHMIDT, C.J., ABBATE, G.M., BLACK, C.K. & TAYLOR, V.L. (1990a). Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther., 255, 478-483.
53. SCHMIDT, C.J., BLACK, C.K. & TAYLOR, V.L. (1990b). Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur. J. Pharmacol., 181, 59-70.
54. SCHMIDT, C.J., BLACK, C.K. & TAYLOR, V.L. (1991). L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine to rats. Eur. J. Pharmacol, 203, 41-49.
55. SCHMIDT, C.J. & KEHNE, J.II. (1990). Neurotoxicity of MDMA: neurochemical effects. Ann. N.Y. Acad. Sei., 600, 665-681.
56. SCHMIDT, C.J., RITTER, J.K., SONSALLA, P.K., HANSOM, G.R. & GIBB, J.W. (1987). Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther., 233, 539-544.
57. SCHMIDT, C.J., SULLIVAN, C.K. & FADAYEL, G.N. (1994). Blockade of striatal 5-hydroxytryptamine2 receptors reduced the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J. Neurochem.. 62, 1382-1389.
58. SCHMIDT, C.J., WU, L. & LOVENBERG, W. (1986). Methylenedioxy methamphetamine: a potentially neurotoxic amphetamine analogue. Eur. J. Pharmacol., 124, 175-178.
59. SHARKEY, j., MCBEAN, D.E. & KELLY, P.A.T. (1991). Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Psychopharmacology, 105, 113-118.
60. SPANOS, L.J. & YAMAMOTO, B.K. (1989). Acute and subchronic effects of methylenedioxymethamphetamine fMDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol. Biochem. Behar., 32, 835-840.
61. STEELE, T.D., McCANN, U.D. & RICAURTE, G.A. (1994). 3,4methylenedioxymethamphetamine (MDMA, 'Ecstasy'); pharmacology and toxicology in animals and humans. Addiction, 89, 539-551.
62. STEELE, T.D., NICHOLAS, D.E. & YIM, G.K.W. (1987). Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol.. 36, 2297-2303.
63. STONE, D.M., JOHNSON, M., HANSON, G.R. & GIBB, J.W. (1988). Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther., 247, 79-87.
64. STONE, D.M., STAHL, D.C., HANSON, G.R. & GIBB, J.W. (1986). The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol., 128, 41 -48.
65. WESTERINK, B.H.C. & SPAAN, S.J. (1982). On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. J. Nenrochem., 38, 680-686.
66. WHITE, S.R., OBRADOVIC, T., IMEL, K.M. & WHEATON, M.J. (1996). The effects of methylenedioxymethamphetamine (MDMA, 'ecstasy') on monoaminergic neurotransmission in the central nervous system. Progr. NeurobioL, 49, 455-479.
67. YAMAMOTO, B.K., NASH, J.F. & GUDELSKY, G.A. (1995). Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and γaminobutyric acid in the substantia nigra. J. Pharmacol. Exp Ther.,273, 1063-1070.
68. YAMAMOTO, B.K. & SPANOS, L.J. (1988). The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol., 148, 195-203.